Last 6.19 INR
Change Today 0.00 / 0.00%
Volume 0.0
CLZ On Other Exchanges
Symbol
Exchange
Mumbai
As of 6:00 AM 07/11/14 All times are local (Market data is delayed by at least 15 minutes).

colinz laboratories ltd (CLZ) Snapshot

Open
6.19
Previous Close
6.19
Day High
6.19
Day Low
6.19
52 Week High
08/14/13 - 6.90
52 Week Low
12/24/13 - 2.90
Market Cap
28.3M
Average Volume 10 Days
11.0
EPS TTM
0.24
Shares Outstanding
4.6M
EX-Date
--
P/E TM
25.8x
Dividend
--
Dividend Yield
--
Current Stock Chart for COLINZ LABORATORIES LTD (CLZ)

Related News

No related news articles were found.

colinz laboratories ltd (CLZ) Related Businessweek News

No Related Businessweek News Found

colinz laboratories ltd (CLZ) Details

Colinz Laboratories Limited manufactures and markets pharmaceutical formulations primarily for the gynaecological sector in India. The company provides specialty products in the dosage form of tablets, capsules, parenterals, creams/ointments/lotions, dry powder, liquid orals, and soft gelatine capsules. It offers its products in various therapeutic areas, including anti biotics and anti bacterials, anti hypertensives, diuretics, lipid lowering agents, anti emetics, anti fungals, pain killers and musculo skeletals, anxiolytics, anti allergics, anti cold and anti cough, nasal decongestants, anti diarrhoeals, gastro intestinals/antacids, anti helmintics, laxatives and purgatives, enzymes, vitamins and tonics, iron, calcium, amino acids, anti piles, anti malarials, skin creams, eye drops, and ear drops, as well as drugs used in protozoal infections. In addition, the company provides veterinary formulations, such as feed mixes, bolus, vitamins, and other products; nutraceuticals; herbal preparations comprising pain balms and anti cold rubs; ayurvedic skin care creams for the treatment of pimples, fairness, stretch marks, and cracks; and capsules/tablets/ creams/ powders for anti piles, laxatives, anti diabetic, anti hypertensive, antacid, vigour and vitality, and general debility. Further, it sources API/intermediates; and provides product development and clinical research services, technical know how for formulations, and contract manufacturing services. The company was incorporated in 1986 and is based in Mumbai, India.

Founded in 1987

colinz laboratories ltd (CLZ) Top Compensated Officers

Chairman, Managing Director, Chief Executive ...
Total Annual Compensation: 885.5K
Whole-Time Director
Total Annual Compensation: 795.5K
Compensation as of Fiscal Year 2013.

colinz laboratories ltd (CLZ) Key Developments

Colinz Laboratories Ltd. Announces Un-Audited Earnings Results for the Fourth Quarter and Audited Earnings Results for the Full Year Ended March 31, 2014

Colinz Laboratories Ltd. announced un-audited earnings results for the fourth quarter and audited earnings results for the full year ended March 31, 2014. For the quarter, the company announced net sales of INR 17.976 million compared to INR 16.201 million a year ago. Profit from operations before other income was INR 0.130 million compared to INR 0.690 million a year ago. Profit before tax was INR 0.542 million compared to INR 0.489 million a year ago. Net profit was INR 0.542 million compared to INR 0.489 million a year ago. For the full year, the company announced net sales of INR 74.026 million compared to INR 71.536 million a year ago. Profit from operations before other income was INR 0.833 million compared to INR 2.845 million a year ago. Profit before tax was INR 1.265 million compared to INR 1.599 million a year ago. Net profit was INR 0.665 million compared to INR 0.798 million a year ago.

Colinz Laboratories Ltd., Board Meeting, May 30, 2014

Colinz Laboratories Ltd., Board Meeting, May 30, 2014. Agenda: To approve and take on record the un-audited earnings results for the fourth quarter and audited earnings results for the full year ended March 31, 2014.

Colinz Laboratories Ltd. Announces Unaudited Earnings Results for the Third Quarter and Nine Months Ended December 31, 2013

Colinz Laboratories Ltd. announced unaudited earnings results for the third quarter and nine months ended December 31, 2013. For the quarter, the company reported net sales/income from operations of INR 18,287,000 compared to INR 15,736,000 for the same period a year ago. Loss from operations before other income was INR 66,000 compared to profit from operations before other income of INR 569,000 for the same period a year ago. Profit from ordinary activities before tax was INR 300,000 compared to INR 148,000 for the same period a year ago. Net profit from ordinary activities after tax was INR 300,000 compared to INR 148,000 for the same period a year ago. For the nine months, the company reported net sales/income from operations of INR 56,052,000 compared to INR 55,335,000 for the same period a year ago. Profit from operations before other income was INR 703,000 compared to INR 2,156,000 for the same period a year ago. Profit from ordinary activities before tax was INR 723,000 compared to INR 1,111,000 for the same period a year ago. Net profit from ordinary activities after tax was INR 723,000 compared to INR 1,111,000 for the same period a year ago.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
CLZ:IN 6.19 INR 0.00

CLZ Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for CLZ.
View Industry Companies
 

Industry Analysis

CLZ

Industry Average

Valuation CLZ Industry Range
Price/Earnings 41.2x
Price/Sales 0.4x
Price/Book 0.4x
Price/Cash Flow 8.6x
TEV/Sales NM Not Meaningful
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact COLINZ LABORATORIES LTD, please visit www.colinz.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.